EDESA BIOTECH, INC. Payments for Purchase of Other Assets
EDESA BIOTECH, INC. (EDSA) reported Payments for Purchase of Other Assets of $0 for the 12-month period ending 2021-09-30, per its 10-K filed 2021-12-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForPurchaseOfOtherAssets1 · last filed 2021-12-28
- EDESA BIOTECH, INC. payments for purchase of other assets for the quarter ending 2021-09-30 was $0.00.
- EDESA BIOTECH, INC. payments for purchase of other assets for the quarter ending 2020-09-30 was $0.00.
- EDESA BIOTECH, INC. payments for purchase of other assets for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- EDESA BIOTECH, INC. payments for purchase of other assets for fiscal 2020 was $29.48K.
| Period end | Payments for Purchase of Other Assets 3 month | Payments for Purchase of Other Assets 9 month | Payments for Purchase of Other Assets 12 month |
|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | $0.00 10-K · filed 2021-12-28 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-13 | ||
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | $29.48K 10-K · filed 2021-12-28 | |
| 2020-06-30 | $29.48K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |